Notices. Notice of application
296 words·~1 min read·
/register/2019/10/22/2019-23012A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4332-90-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-524] Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc. ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 23, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention:
DEA **Federal Register** Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on September 10, 2019, Johnson Matthey, Inc., 2003 Nolte Drive, West Deptford, New Jersey 08066-1743 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Schedule Gamma Hydroxybutyric Acid 2010 I Marihuana 7360 I Tetrahydrocannabinols 7370 I Dihydromorphine 9145 I Difenoxin 9168 I Amphetamine 1100 II Methamphetamine 1105 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Nabilone 7379 II Cocaine 9041 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Diphenoxylate 9170 II Ecgonine 9180 II Hydrocodone 9193 II Levorphanol 9220 II Meperidine 9230 II Methadone 9250 II Methadone intermediate 9254 II Morphine 9300 II Thebaine 9333 II Opium tincture 9630 II Oxymorphone 9652 II Noroxymorphone 9668 II Alfentanil 9737 II Remifentanil 9739 II Sufentanil 9740 II Tapentadol 9780 II Fentanyl 9801 II The company plans to bulk manufacture the listed controlled substances for internal use as intermediates or for sale to its customers.
In reference to drug codes 7360 (marihuana), and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: October 9, 2019. William T. McDermott, Acting Assistant Administrator. [FR Doc. 2019-23012 Filed 10-21-19; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources